Midtelephone conversation, Pam Fitzgerald pauses. Her dog’s barking at the FedEx truck. “Oh, it’s my medicine being delivered,” she says matter-of-factly. Daily medicine keeps her moving forward, for now.

Barbara Mohler has been fighting breast cancer for 37 years. First diagnosed in 1980, she has battled many recurrences. “For a long time, I felt like I was just one of many,” she says. Unsatisfied with that feeling, in 2002, she placed a call to Johns Hopkins, hoping to find a different path for her care.

Breast Cancer Program Director Vered Stearns says that was the inspiration for a new patient app, funded by Under Armour, that puts just about anything breast cancer patients need or want to know in the palm of their hands.

In an early clinical trial, a new drug called CPI-444 appears to keep cancer in check, alone and in combination with another immunotherapy.

Breast cancer researchers Sara Sukumar, Ph.D., and Mary Jo Fackler, Ph.D., developed a blood test that identifies breast cancers at greatest risk of recurrence.

Every month, breast cancer physicians, nurses and other staff gather for a lunch that has become a time to reflect and heal, in acknowledgment of patients lost and the challenging and stressful jobs they have.

Young women facing a breast cancer diagnosis and treatment often find it challenging to juggle treatment with caring for their family, the demands of their job and other pressures of day-to-day life.

Brenda Cho was a working mother of a 2-year-old and 4-year-old when she received a diagnosis of stage 4 metastatic breast cancer in March 2015.

Saturday, May 13, 2017, marked the first annual Survivor Soul Stroll to raise money and awareness for breast cancer research.

Learn more about the research supported by the John Fetting Fund for Breast Cancer Prevention.

Adoptive T cell therapy is a type of immunotherapy that relies on identifying killer T cells that react to mutant proteins from a patient’s own tumor.

The Marcie and Ellen Foundation, in memory of Marcie Westermeyer and Ellen Ervin, donates all of its proceeds from an annual benefit dinner to support the research of the Kimmel Cancer Center Breast Cancer Program.

Take a look at the construction progress for the Skip Viragh Outpatient Cancer Building.

Staying positive and active have propelled Jean through her journey with cancer.

It almost sounds like a made up word, but the spliceosome is a very real and very complex molecular machine in the nucleus of cells, and it’s at the center of some exciting new Kimmel Cancer Center research.

Find out which team members received awards and honors.